Skip to content
DataLookout
Menu

COCOONNCT07947160

High-flow Nasal Oxygenation in Obese Patients During Colonoscopy: a Randomized Controlled Trial (COCOON)

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Number of participants with at least one episode of oxygen desaturation (SpO2 ≤ 90%) during the procedure
Timeframe: From the start to the end of the procedure (Day 0)

Secondary (6)

Total number of episodes of oxygen desaturation (SpO₂ ≤ 90%) during the procedure
Cumulative duration of oxygen desaturation episodes (SpO2 ≤ 90%) relative to the total duration of the procedure
Occurrence of an episode of hypotension, defined as systolic blood pressure (SBP) < 100 mmHg, during the procedure
Occurrence of an episode of severe bradycardia, defined as heart rate < 40 beats/minute, during the procedure
Use of orotracheal intubation during the procedure
Show 1 moreShow less
Occurrence of a cardiac arrest during the procedure

Arms and interventions

Conventional oxygen therapyActive comparator

Participants assigned to the conventional oxygen therapy group will receive 100% oxygen at 6 L/min through an oxygen capnography mask during the 3-minute pre-oxygenation period and throughout the procedure. After pre-oxygenation, propofol will be administered by target-controlled intravenous infusion, with an initial target concentration of 2 µg/mL. The anesthetist may adjust the target concentration to achieve deep sedation according to American Society of Anesthesiologists (ASA) criteria. The colonoscopy will be performed while participants breathe spontaneously.

High-flow oxygen therapyExperimental

Participants assigned to the high-flow oxygen therapy group will receive 100% oxygen at 50 L/min through an Optiflow® system (Fisher \& Paykel Healthcare) during the 3-minute pre-oxygenation period and throughout the procedure. After pre-oxygenation, propofol will be administered by target-controlled intravenous infusion, with an initial target concentration of 2 µg/mL. The anesthetist may adjust the target concentration to achieve deep sedation according to American Society of Anesthesiologists (ASA) criteria. The colonoscopy will be performed while participants breathe spontaneously.

Devices: Conventional oxygen therapy (oxygen capnography mask), High-flow nasal oxygen therapy (Optiflow®)

Sites

3 sites in 1 country